Funding
This study was funded by Aerie Pharmaceuticals Ireland Ltd. The sponsor funded, designed, and conducted the study, including data collection, management, and interpretation. Additional data management and interpretation was performed by Santen SA, with the support of Jérôme Wojcik (Data2time Sàrl, funded by Santen SA). Medical writing and editorial assistance in the development of this manuscript was provided by Dr Colin Griffin (Griffin Scientific Ltd, UK), funded by Santen SA.